LOS GATOS, MARCH 31 2020 – Scholarly publishing tech provider, HighWire, is pleased to announce that long-term client SNMMI has extended its agreement with HighWire until 2027. The move includes an upgrade of its current journal hosting; renewal of HighWire Submissions; and the addition of data-driven insight services provided through HighWire Analytics.
SNMMI is a nonprofit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging. Its mission is to improve human health by advancing molecular imaging and therapy. HighWire has supported SNMMI’s publishing program for over a decade, hosting a number of its journals and providing additional manuscript submissions and peer review management via HighWire Submissions (previously “BenchPress”) since 2003.
The addition of HighWire Analytics will empower SNMMI further by enabling it to see how its content performs in real-time, with intuitive visual analytics revealing the impact and usage of content, and helping to guide future decisions about its publishing program. This includes features such as HighWire’s patented rejected article tracker (showing where rejected articles end up and the amount of citations they get) and cohort comparison (to track the performance of competitors’ publishing programs).
“The HighWire team has always been responsive to our needs, providing top-notch service and support,” said Susan Alexander, Associate Director of Publications at SNMMI, “The decision to renew and expand our contract with them is reflective of the strength of our relationship, and we look forward to the next 7 years!”
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging, vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s more than 16,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.
Latest news and blog articles
Full-text HTML of preprints now available on medRxiv